سعر سيبتوليت 500 مجم 50 قرصاً 2026

Ceptolate (Mylan / One Pharma Medics, Egypt): mycophenolate mofetil 500 mg tablets; pack of 50.

• Prophylaxis of organ rejection in allogeneic renal, cardiac or hepatic transplant recipients, usually in combination with other immunosuppressants (US mycophenolate mofetil labeling).Population: Transplant recipients as labeledDailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)

• Common: diarrhea, vomiting, leukopenia, anemia, infections, hypertension, edema, hyperglycemia (US MMF labeling — rates vary by transplant type).International label, same formulation · DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)

• Hypersensitivity to mycophenolate mofetil, mycophenolic acid or any component; use in pregnancy is contraindicated for contraception-failure risk context — follow boxed pregnancy prevention requirements on the label used (US labeling).International label, same formulation · DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)

• Embryofetal toxicity — effective contraception required; increased risk of infections (including opportunistic) and malignancies (lymphoma, skin); pure red cell aplasia and neutropenia; GI adverse events including ulceration/bleeding; live vaccines generally avoided (US MMF labeling).International label, same formulation · DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)

• AzathioprineMajorConcomitant use with azathioprine generally not recommended (overlapping myelosuppression/purine antagonism) per MMF labeling.DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)
• Antacids / cholestyramine / bile acid sequestrantsModerateMay decrease mycophenolic acid exposure; separate administration as labeled.DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)

• Mycophenolate is associated with increased risk of first-trimester pregnancy loss and congenital malformations; contraindicated in pregnancy unless no suitable alternative; pregnancy prevention program required (US labeling).General active-ingredient information · DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)
• Mycophenolate is excreted in breast milk; breastfeeding not recommended during treatment and for a period after the last dose per US labeling.General active-ingredient information · DailyMed — Mycophenolate mofetil film-coated tablet (Aurobindo)

• Mycophenolate mofetil: Prodrug hydrolyzed to mycophenolic acid (MPA), a selective uncompetitive IMPDH inhibitor that blocks de novo guanosine nucleotide synthesis and lymphocyte proliferation (US CELLCEPT labeling).